Dr Rebecca Andrews

BMedSci, MBChB, PGCertClinMed, MRCP(UK), PhD

School of Medicine and Population Health

Bicentennial Clinical Research Fellow in Haematology

Haematology Registrar

r.andrews@sheffield.ac.uk
+44 114 215 9209
EU25, E Floor, The Medical School

Full contact details

Dr Rebecca Andrews
School of Medicine and Population Health
EU25, E Floor
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

​​I joined the ±¬ÁÏTV in 2018 as a doctoral clinical fellow within the Sheffield Myeloma Research Team, working with Dr Andrew Chantry and Dr Michelle Lawson. My PhD focused on exploring effects of both current and novel therapies on myeloma bone disease, with the aim to improve clinical outcomes for myeloma patients.  This work also focussed on understanding the role of osteocyte cells and the lacunae canalicular network in cancer induced bone disease.

Following completion of my doctorate studies, I was successful in securing my current post as a post-graduate bicentennial clinical research fellow, which commenced in November 2024. Throughout this fellowship, I have been involved in the design of clinical trials to investigate new treatment strategies to improve myeloma and myeloma bone disease outcomes. In addition, I have ongoing collaborations on both translational and fundamental projects to further develop our understanding of myeloma bone disease pathophysiology.

Alongside this post I have a clinical role at Sheffield Teaching Hospital as a haematology speciality registrar (MRCP 2016). I have also been involved in the co-authorship of the soon to be published myeloma bone disease national guidelines.

Historically, I initially completed my MBChB at the ±¬ÁÏTV in 2012, which included a BMedSci (2009). In 2014 I was successfully awarded a Post-graduate Certificate in Clinical Research. Throughout my career I have been awarded 8 prizes, including a BRS New Investigator Award and a plenary oral award at the international CABS meeting in 2024.

I have been an elected committee member of the Bone Research Society (BRS) since 2024, and have been a member of the society since 2018. I have also been a UK Myeloma Society member since 2018 and a member of the International Myeloma Society since 2025. Locally, I hold a leadership role as a co-organiser of the post-graduate Division Research & Innovation Exchange (DRIvE) seminar series.

Research interests

  • Multiple myeloma

  • Myeloma bone disease

  • Cancer-induced bone disease

  • Osteocytes

Publications

Journal articles

  • Stewart G, Tazzyman S, Sun Y, Andrews RE, Harrison J, Lath D, Down J, Robinson G, Wang X, Muthana M , Chantry AD et al (2025) . Leukemia, 39(6), 1449-1463.
  • (2024) . JBMR Plus, 8(10).
  • Evans H, Andrews R, Abedi FA, Sprules A, Trend J, Lovric G, Green A, Chantry A, Clarkin C, Brown J & Lawson M (2024) . JBMR Plus, 8(9).
  • Diaz-delCastillo M, Palasca O, Nemler TT, Thygesen DM, Chávez-Saldaña NA, Vázquez-Mora JA, Ponce Gomez LY, Jensen LJ, Evans H, Andrews RE , Mandal A et al (2023) . The Journal of Neuroscience, 43(29), 5414-5430.
  • Diaz-delCastillo M, Nemler T, Thygesen DM, Chávez-Saldaña NA, Vázquez-Mora JA, Palasca O, Juhl L, Evans H, Andrews RE, Mandal A , Chantry AD et al (2022) . Clinical Lymphoma Myeloma and Leukemia, 22, S108-S108.
  • Andrews RE, Brown JE, Lawson MA & Chantry AD (2021) . Journal of Clinical Medicine, 10(17).
  • Diaz-delCastillo M, Andrews RE, Mandal A, Andersen TL, Chantry AD & Heegaard A-M (2021) . Cancers, 13(7).
  • Kurien M, Andrews RE, Tattersall R, McAlindon ME, Wong EF, Johnston AJ, Hoeroldt B, Dear KL & Sanders DS (2017) . Clinical Gastroenterology and Hepatology, 15(7), 1047-1054.
  • Andrews RE, Shah KM, Wilkinson JM & Gartland A (2011) . Bone, 49(4), 717-723.

Book chapters

  • Andrews RE, Chantry AD & Ashcroft AJ (2021) , Management of Bone Disease and Kidney Failure in Multiple Myeloma (pp. 7-36). Springer International Publishing
  • Andrews RE, Chantry AD & Ashcroft AJ (2021) , Management of Bone Disease and Kidney Failure in Multiple Myeloma (pp. C1-C5). Springer International Publishing
  • Green AC, Andrews RE & Lawson MA (2020) , Encyclopedia of Bone Biology (pp. 180-200). Elsevier
  • Green AC, Andrews RE & Lawson MA (2020) , Encyclopedia of Bone Biology (pp. V3-V3-200).

Conference proceedings

  • Christensen MSJ, Andrews RE, Mandal A, Chantry AD, Andersen TL, Heegaard A-M & del Castillo MD (2024) Multiple myeloma induces angiogenesis and neuronal degeneration in the human hematopoietic bone marrow. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 39 (pp 15-15)
  • Diaz-DelCastillo M, Nemler T, Thygesen DM, Chavez-Saldana NA, Vazquez-Mora JA, Palasca O, Juhl L, Evans H, Andrews RE, Mandal A , Chantry AD et al (2023) Mechanisms of Bone Pain in Multiple Myeloma: Involvement of Periosteal Bone Sprouting. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 38 (pp 55-56)
  • Ros-Soto J, Matthews NC, Burton C, Szydlo R, Alfred A, Andrews R, Anthias C, Mehra V, Potter V, Madrigal A & Snowden JA (2022) Association between vitamin d and GVHD biomarkers with response to immunosuppression and survival in acute GVHD: An exploratory study. BONE MARROW TRANSPLANTATION, Vol. 57(SUPPL 1) (pp 216-216)
  • Diaz-delCastillo M, Nemler T, Thygesen DM, Chavez-Saldana NA, Vazquez-Mora JA, Palasca O, Juhl L, Evans H, Andrews RE, Mandal A , Chantry AD et al (2022) Myeloma-induced bone pain: lessons learnt from a localized, immunocompetent mouse model. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Vol. 22 (pp S108-S108)
  • Andrews RE, Kurien M, Leeds JS, Grant J, McAlindon ME & Sanders DS (2014) . Gut, Vol. 63(Suppl 1) (pp A11.2-A12)
  • Andrews RE, Brooks AJ, Evans KE, Page K & McAlindon ME (2011) . Gut, Vol. 60(Suppl 1) (pp A94.1-A94)
  • Andrews R, Wilkinson J & Gartland A (2010) . Bone, Vol. 46 (pp S71-S71)

Preprints

  • Andrews RE, Jolly I, Brown JE, Lawson MA & Chantry AD (2026) , openRxiv.
  • Diaz-delCastillo M, Palasca O, Nemler TT, Thygesen DM, Chávez-Saldaña NA, Vázquez-Mora JA, Ponce Gomez LY, Jensen LJ, Evans H, Andrews RE , Mandal A et al (2022) , openRxiv.